Department of Cadiac Anesthesiology, Medical University of Gdańsk
Gdansk, Pomeranian Voivodeship, 80-211, Poland
NCT Number: NCT04828902
Postoperative delirium is an acute syndrome of mental deterioration characterized by acute onset and fluctuating course during the day. Very frequent delirium is a presage of other serious comorbidities i.e.: sepsis, acute kidney injury, circulatory and/or respiratory failure. A detailed knowledge of symptoms and early diagnose of delirium increase the chances of early therapy. To what extent the occurrence of postoperative delirium influences hospital therapy in the Cardiac Surgical Postoperative ICU in University Clinical Centre in Gdańsk is unknown so far.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Gdansk, Pomeranian Voivodeship, 80-211, Poland
Study type: prospective, observational cohort study. Facility: tertiary, university hospital Methods: Patients will undergo routine, continuous observation for symptoms of delirium by a trained nursing staff. Occurrence of delirium, Delirium Observation Screening Scale (DOSS) grading, and therapy will by annotated on case record forms (CRFs) every 12 hours. Additionally, collected will be known risk factors of delirium: schedule type, age, arterial hypertension, atrial fibrillation, body mass index (BMI), angiotensin converting enzyme (ACE) inhibitors / angiotensin receptor blockers (ARBs) therapy, hearing loss, dementia, peripheral artery disease, myocardial infarction, depression, diabetes, corona virus disease 2019 (COVID19) infection and/or vaccination; and outcome data: hospital-LOS, prolonged sedation, antipsychotic therapy, surgical reintervention, hours on mechanical ventilation (HOV), number of tracheal intubations, length of consciousness disorders, blood product transfusions, cardiopulmonary resuscitation (CPR), renal replacement therapy (RRT), mechanical circulatory support (MCS), duration of catecholamine support, ICU readmissions, new antibiotic therapies, 30-day mortality.
Statistical methods: Delirium morbidity and risk will be calculated from two-by-two table. Associations between delirium and secondary outcome measures will be evaluated by simple and logistic regression with use of ANOVA test for continuous variables with homogeneous distribution, or Kruskal-Wallis test for continuous variables with non-homogeneous distribution, or categorical variables. Significant will be considered results with p<0.05.
A period of one year was assumed sufficient to draw conclusions on the primary endpoints of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Any heart surgery on or without cardiopulmonary bypass performed under general anesthesia in the Cardiac Surgical Department, Medical University of Gdańsk.
Other names: cabg, valve surgery, aorta surgery, heart transplant, other cardiac surgery
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Incidence and risk of postoperative delirium
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
collected will be known risk factors of delirium: schedule type, age, arterial hypertension, atrial fibrillation, BMI, ACE/ARBs therapy, hearing loss, dementia, peripheral artery disease, myocardial infarction, depression, diabetes, COVID19 and/or vaccination for it; and outcome data: hospital-LOS, prolonged sedation, antipsychotic therapy, surgical reintervention, direct coercion, length of mechanical ventilation, number of tracheal intubations, length of consciousness disorders, blood product transfusions, cardiopulmonary resuscitation, renal replacement therapy, mechanical circulatory support, duration of catecholamine support, ICU readmissions, new antibiotic therapies, 30-day mortality.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and length of stay in ICU (LOS-ICU).
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Associations between delirium and mean DOSS
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and hospital-LOS
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and prolonged sedation, antipsychotic therapy, surgical reintervention.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and HOV.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and number of tracheal intubations.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and length of consciousness disorders.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and blood product transfusions.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and CPR, RRT, and MCS.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and duration of catecholamine support.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and ICU readmissions.
Time frame: Through hospitalisation in Postop-ICU - an average of 2 days
Association between delirium and new antibiotic therapy.
Time frame: 30 days after operation
Association between delirium and 30-day mortality
Medical University of Gdansk
Other
Incidence of Postoperative Delirium After Cardiac Surgery in Adults - a Prospective Observational Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05823844
Confusion, Delirium
New York, United States
View Trial DetailsNCT07714928
Cognition Disorders, Cognitive Dysfunction
Örebro, Sweden
View Trial DetailsNCT05574400
Alzheimer Disease, Brain Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT06115031
Confusion, Delirium
Seoul, South Korea
View Trial Details